Pharmaceuticals:
Betting on Biotech to Transform Guangdong, China's Export Hub
Richard Stone
Shanghai is the undisputed center of gravity for biopharma in China, and ambitious high-tech parks have taken root in Suzhou, Tianjin, and elsewhere. Now local officials are betting that biotech will help wean Guangdong Province off its heavy dependence on cheap exports. Among the new initiatives, Guangdong is developing a "Biotech Island" off Guangzhou and is about to launch a program to reel in at least 100 overseas scientists to commercial labs, universities, and state research institutes.